4-hydroxyestrone-4-methyl ether
CAS No. 58562-33-7
4-hydroxyestrone-4-methyl ether ( 4-Methoxy Estrone )
Catalog No. M28697 CAS No. 58562-33-7
4-hydroxyestrone-4-methyl ether is the methylation of 4-OHE1, which is catalyzed by COMT.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
100MG | Get Quote | Get Quote |
|
200MG | Get Quote | Get Quote |
|
500MG | Get Quote | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product Name4-hydroxyestrone-4-methyl ether
-
NoteResearch use only, not for human use.
-
Brief Description4-hydroxyestrone-4-methyl ether is the methylation of 4-OHE1, which is catalyzed by COMT.
-
Description4-hydroxyestrone-4-methyl ether is the methylation of 4-OHE1, which is catalyzed by COMT.(In Vitro):4-hydroxyestrone-4-methyl ether(10 and 100 nM) increases the proliferation of human umbilical vein endothelial cells (HUVECs).
-
Synonyms4-Methoxy Estrone
-
PathwayEndocrinology/Hormones
-
TargetEstrogen Receptor/ERR
-
RecptorApoptosis
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number58562-33-7
-
Formula Weight599.8
-
Molecular FormulaC38H47O6
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC[C@](CC1)([C@@H](CC2)[C@H](CC3)[C@H]1c(cc1)c3c(OC)c1O)C2=OC[C@](CC1)([C@@H](CC2)[C@H](CC3)[C@H]1c(cc1)c3c(OC)c1O)C2=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Salehi AH, et, al. AEG3482 is an antiapoptotic compound that inhibits Jun kinase activity and cell death through induced expression of heat shock protein 70. Chem Biol. 2006 Feb;13(2):213-23.
molnova catalog
related products
-
Segetalin B
Segetalin B is a natural product from Vaccaria segetalis (Neck.) Garcke, has estrogen-like activity.
-
Medroxyprogesterone
Medroxyprogesterone is used in the treatment of renal carcinoma. It is a synthetic progestational hormone used in veterinary practice as an estrus regulator.
-
glutamic acid
(S)-Glutamic acid acts as an excitatory transmitter, shows a direct activating effect on the release of DA from dopaminergic terminals.